Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.
The Agilent NovoCyte Quanteon flow cytometer and xCELLigence Real-Time Cell Analysis platform were used to develop a series of in vitro preclinical CAR T-cell safety and efficacy assays Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results